August Bogina, III v. Medline Industries, Incorpora

809 F.3d 365, 2016 U.S. App. LEXIS 8, 2016 WL 25611
CourtCourt of Appeals for the Seventh Circuit
DecidedJanuary 4, 2016
Docket15-1867
StatusPublished
Cited by37 cases

This text of 809 F.3d 365 (August Bogina, III v. Medline Industries, Incorpora) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
August Bogina, III v. Medline Industries, Incorpora, 809 F.3d 365, 2016 U.S. App. LEXIS 8, 2016 WL 25611 (7th Cir. 2016).

Opinion

POSNER, Circuit Judge.

This appeal is from the dismissal of a suit filed in 2011 under the False Claims Act, 31 U.S.C. §§ 3729 et seq., by a private individual named Bogina on behalf of the United States. He seeks a bounty for exposing fraud that the Medline Industries and the Tutera Group (and Tutera affiliates unnecessary to discuss), have allegedly perpetrated against both the federal government, see 31 U.S.C. § 3730, and *367 several state governments on whose behalf Bogina is also suing (they are the “et al.” in the caption). He bases federal jurisdiction of the state claims on the supplemental jurisdiction of the federal courts. See 31 U.S.C. § 3732(b); 28 U.S.C. § 1367. The district judge dismissed the federal claims as being too similar to those in a prior suit against Medline to authorize Bo-gina’s suit. The judge then relinquished jurisdiction over the state claims to the state courts, see 28 U.S.C. § 1367(c); about those claims we need say no more.

Medline is a major seller of medical equipment to institutions reimbursed by Medicare and similar federal programs for part of the price they pay for their medical supplies. The Tutera Group is a chain of nursing homes that is a Medline customer. Bogina claims to have discovered through his business associate Michael- Tutera, a former member of the ownership group of the Tutera Group and brother of one of its current principals, that Medline gives bribes and kickbacks to the Tutéra Group to induce it to purchase from Medline.

We’ll see that Medline has been sued before for engaging in such conduct, though until the present suit the Tutera Group had not been specifically accused of being one of Medline’s partners in fraud. Some of the corrupt payments that Med-line has been accused of making are in the form of lump-sum cash payments, and thus conventional bribes; others are kickbacks — returning some of the purchase price to the purchaser off book, thus inducing him to buy from Medline rather than from a competitor. Whether bribes or kickbacks, such payments. operate as discounts to Medline customers, and discounts are normally an innocent means of competing. But not discounts in the form of bribes and kickbacks to government contractors. For then the purchaser of a discounted item will seek reimbursement from the government of the authorized percentage of the price charged the purchaser (Tutera being the purchaser identified by Bogina) by the seller (Medline)— including the part of that price that the seller rebates to the purchaser. And as a result the government makes inflated reimbursements and medical providers are induced to purchase from the discounting seller even if substitute products of the same or higher quality are available at lower prices from other sellers. In submitting these inflated claims for reimbursement the purchasers also falsely certify compliance with federal anti-bribery and anti-kickback laws.

So suppose the nominal price of a piece of equipment sold by Medline is $100,000 but Medline kicks back $10,000 to the buyer. The buyer’s cost is only $90,000 but he would report it to the government as $100,000 and thus receive a greater reimbursement than he was entitled to. That is fraud and a person (or a firm or other institution) violates the False Claims Act if he “knowingly presents, or causes to be presented, a false or fraudulent claim for payment or approval” by the government. 31 U.S.C. § 3729(a)(1)(A) (emphasis added). Bogina contends that at Medline’s behest the Tutera Group submitted to the federal government fraudulent claims for reimbursement. If this is correct, both the Tutera Group and Medline defrauded the government.

Bogina is thus suing as a volunteer on behalf of the federal government — a kind of private attorney general — in the hope of course of being handsomely compensated if the suit succeeds. (We’ll encounter such compensation shortly.) He thus is a bounty hunter, and federal law places some obstacles in the path of its bounty hunters. Thus 31 U.S.C. § 3730(e)(4)(A), as it read during the kickback scheme of which Bogina accuses the *368 defendants (2003 to 2009), allowed a private person to bring a false-claims suit- on behalf of the government “based on public allegations” only if he was “an original source of the information.” A 2010 amendment changed “based on public allegations” to “if substantially the same allegations ... as alleged in the action or claim [had been] publicly disclosed.” But this was not a significant change, both formulas being aimed at barring “ ‘me too’ private litigation [that] would divert funds from the Treasury” to bounty seekers whose efforts had duplicated those of the government or an earlier bounty seeker. United States ex rel. Goldberg v. Rush University Medical Center, 680 F.3d 933, 934 (7th Cir.2012); see also Glaser v. Wound Care Consultants Inc., 570 F.3d 907, 919-20 (7th Cir.2009); United States ex rel. Gear v. Emergency Medical Associates of Illinois, Inc., 436 F.3d 726, 729 (7th Cir.2006). “[P]ublic disclosures bar qui tam actions against any defendant who is directly identifiable from the public disclosures,” even if not specifically named. Id. (The phrase “qui tam” is short for qui tam pro domino rege quam pro se ipso in hoc parte sequitur, meaning “who [qui] sues in this matter for the king as well as [tam ] for himself.” The “for himself’ part is the hoped-for bounty.)

Before the 2010 amendment “original source” was defined as “an individual who has direct and independent knowledge of the information on which the allegations [in his complaint] are based.” 31 U.S.C. § 3730(e)(4)(B) (1994). The definition was unsatisfactory, because what “direct” adds to “independent” as a modifier of “knowledge” is inscrutable. Could “direct” mean that even reliable hearsay cannot be deemed a source of knowledge, that it must be classified as indirect? There is the hint of a positive answer in Leveski v. ITT Educational Services, Inc., 719 F.3d 818, 837 (7th Cir.2013). (Glaser v. Wound Care Consultants Inc., supra, 570 F.3d at 921 n.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
809 F.3d 365, 2016 U.S. App. LEXIS 8, 2016 WL 25611, Counsel Stack Legal Research, https://law.counselstack.com/opinion/august-bogina-iii-v-medline-industries-incorpora-ca7-2016.